Consistency of the Efficacy and Safety Profile of Sotatercept across Baseline Cardiac Index Subgroups: A Pooled Analysis of STELLAR and PULSAR Trials

Purpose: Compare efficacy/safety of the activin signaling inhibitor, sotatercept (SOTA), across subgroups defined by baseline cardiac index (CI) value

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , D.B. Badesch, J.R. Gibbs, E. Grunig, M.M. Hoeper, M. Humbert, G. Kopec, V.V. McLaughlin, G. Meyer, K.M. Olsson, I. Preston, S. Rosenkranz, R. Souza, A. Waxman, L. Perchenet, J. Strait, A. Xing, A.O. Johnson-Levonas, A.G. Cornell, J. de Oliveira Pena, H. Source Type: research